|
|
 |
|
Viewing report
|
|
|
Mitsubishi Tanabe Pharma Corporation: PharmaVitae Profile
Datamonitor, June 2010, Pages: 64
This analysis examines the historical and forecast performance for Mitsubishi Tanabe in the Rx drug sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Key reasons to purchase this title
- Benchmark Mitsubishi Tanabe's performance against key rivals in the prescription pharmaceutical sector
- Assess how the merger of Mitsubishi and Tanabe has provided scale, re-focused the company's strategic priorities and resource capabilities
- Assess how Mitsubishi Tanabe's launch portfolio is forecast to offset the sluggish sales growth of its aging marketed portfolio
|
|
|
|
